Four Florida Women Indicted in $14.6B National Health Fraud and Opioid Scheme – Medicare

Pensacola, FL — Four women from Pensacola have been indicted in connection with an alleged prescription drug diversion scheme, as part of a broader federal crackdown on healthcare fraud and illegal opioid distribution.

The U.S. Department of Justice announced the charges as part of its 2025 National Health Care Fraud Takedown, a nationwide law enforcement initiative targeting healthcare-related crimes. The operation has led to charges against 324 individuals and the seizure of over $245 million in cash, vehicles, and luxury assets.

Individuals Charged

The following women face federal charges for their alleged roles in the scheme:

• Alexandra M. Christensen, 31
• Lindsay N. McCray (also known as Lindsay Rogers), 41
• Heather T. Bradley (also known as Heather Thomas), 36
• Jennifer E. Purves, 39

According to court documents, the women are accused of distributing large quantities of controlled substances — specifically hydrocodone and oxycodone — without proper authorization.

Details of the Alleged Scheme

• McCray and Christensen are charged with conspiracy to distribute and dispense controlled substances.
• Bradley, Purves, and McCray are charged with the distribution of controlled substances.
• Between 2015 and 2024, McCray allegedly forged prescriptions while working at an undisclosed medical facility in Florida.
• The group is accused of unlawfully distributing over:
  • 300,000 hydrocodone pills
  • 30,000 oxycodone pills

Part of a Larger Federal Initiative

Federal authorities say this case is just one piece of a much larger investigation into fraud and drug diversion schemes that have cost taxpayers over $14.6 billion in attempted losses and resulted in the illegal distribution of more than 15 million prescription pills.

In a press release, the DOJ stated, “The defendants allegedly defrauded programs entrusted for the care of the elderly and disabled to line their own pockets.”

The takedown reflects ongoing efforts by federal agencies to clamp down on the opioid epidemic and prevent the misuse of taxpayer-funded healthcare programs.